Tusk Therapeutics Ltd. is a biotechnology company based in London, specializing in the development of innovative therapies for cancer and autoimmune diseases. The organization focuses on harnessing the power of the immune system to create targeted treatments that enhance patient outcomes. With a commitment to advancing therapeutic solutions, Tusk Therapeutics is engaged in cutting-edge research and development, aiming to address unmet medical needs in the biopharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

12 Patents

#283 in London

#1,458 in United Kingdom

#48,163 in the World

London, United Kingdom

Tusk Therapeutics Ltd.

Forward Citations = 30

12 inventors:

Sergio Quezada (12 out of 13 patents)

Anne Goubier (12 out of 20 patents)

Beatriz Goyenechea Corzo (12 out of 20 patents)

4. Josephine Salimu (12 out of 20 patents)

5. Kevin Moulder (12 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tusk Therapeutics Ltd.. Retrieved from https://idiyas.com/company/tusk-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

10 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]